Prognostic Value of Admission Mean Corpuscular Volume for Major Adverse Cardiovascular Events Following Stent Implantation in Nondiabetic and Diabetic Patients with Acute Coronary Syndrome

Overview

Journal Dis Markers

Publisher Wiley

Specialty Biochemistry

Date 2020 Aug 1

PMID 32733619

Citations 3

Authors

Lele Cheng

Lisha Zhang

Junhui Liu

Wenyuan Li

Xiaofang Bai

Ruifeng Li

Bolin Li

Lijun Wang

Juan Zhou

Yue Wu

Zuyi Yuan

Affiliations

Soon will be listed here.

Abstract

Background: One of the key concerns of the clinician is to identify and manage risk factors for major adverse cardiovascular events (MACEs) in nondiabetic and diabetic patients with acute coronary syndrome (ACS) undergoing stent implantation. Mean corpuscular volume (MCV) is a marker of erythrocyte size and activity and is associated with prognosis of cardiovascular disease. However, the role of admission MCV in predicting MACEs following stent implantation in diabetes mellitus (DM), non-DM, or whole patients with ACS remains largely unknown.

Methods And Results: A total of 437 ACS patients undergoing stent implantation, including 294 non-DM (59.08 ± 10.24 years) and 143 DM (63.02 ± 9.92 years), were analyzed. Admission MCV was higher in non-DM than DM patients. During a median of 31.93 months follow-up, Kaplan-Meier curve demonstrated that higher admission MCV level was significantly associated with increased MACEs in whole and non-DM, but not in DM patients. In Cox regression analysis, the highest MCV tertile was associated with higher MACEs in whole ([HR] 1.870, 95% CI 1.113-3.144, = 0.018), especially those non-DM ([HR] 2.089, 95% CI 1.077-4.501, = 0.029) patients after adjustment of several cardiovascular risk factors. MCV did not predict MACEs in DM patients. During landmark analysis, admission MCV showed better predictive value for MACEs in the first 32 months of follow-up than in the subsequent period. Finally, the receiver operating characteristic (ROC) curve was conducted to confirmed the value of admission MCV within 32 months.

Conclusion: In patients with ACS, elevated admission MCV is an important and independent predictor for MACEs following stent implantation, especially amongst those without DM even after adjusting for lifestyle and clinical risk factors. However, as the follow-up period increased, the admission MCV lost its ability to predict MACEs.

Citing Articles

Predictive role of hematological indices in patients with acute coronary syndrome in Ethiopia: Intrahospital outcomes.

Tadesse S, Tegene E, Yilma D, Yemane T, Gudina E, Mossie A Heliyon. 2024; 10(17):e36790.

PMID: 39281553 PMC: 11401069. DOI: 10.1016/j.heliyon.2024.e36790.

Association between biomarkers of inflammation and dyslipidemia in drug resistant tuberculosis in Uganda.

Baluku J, Nalwanga R, Kazibwe A, Olum R, Nuwagira E, Mugenyi N Lipids Health Dis. 2024; 23(1):65.

PMID: 38429714 PMC: 10905847. DOI: 10.1186/s12944-024-02063-7.

Relationship between Red Blood Cell Indices (MCV, MCH, and MCHC) and Major Adverse Cardiovascular Events in Anemic and Nonanemic Patients with Acute Coronary Syndrome.

Zhang Z, Gao S, Dong M, Luo J, Xu C, Wen W Dis Markers. 2022; 2022:2193343.

PMID: 36393972 PMC: 9649320. DOI: 10.1155/2022/2193343.

References

Sun L, Zhang C, Ju Y, Tang B, Gu M, Pan B . Mean Corpuscular Volume Predicts In-Stent Restenosis Risk for Stable Coronary Artery Disease Patients Receiving Elective Percutaneous Coronary Intervention. Med Sci Monit. 2019; 25:3976-3982. PMC: 6559005. DOI: 10.12659/MSM.914654. View

Wu T, Fann J, Chen S, Yen A, Wen C, Lu Y . Gradient Relationship between Increased Mean Corpuscular Volume and Mortality Associated with Cerebral Ischemic Stroke and Ischemic Heart Disease: A Longitudinal Study on 66,294 Taiwanese. Sci Rep. 2018; 8(1):16517. PMC: 6224537. DOI: 10.1038/s41598-018-34403-w. View

Ferreira-Gonzalez I, Busse J, Heels-Ansdell D, Montori V, Akl E, Bryant D . Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ. 2007; 334(7597):786. PMC: 1852019. DOI: 10.1136/bmj.39136.682083.AE. View

Kang D, Seo H, Choi B, Lee E, Kim J, Lee S . Absolute change in fasting plasma glucose over 12 months is associated with 2-year and 5-year major adverse cardiovascular events in patients with drug-eluting stent implants. Int J Cardiol. 2014; 179:146-52. DOI: 10.1016/j.ijcard.2014.10.164. View

Cassar A, Holmes Jr D, Rihal C, Gersh B . Chronic coronary artery disease: diagnosis and management. Mayo Clin Proc. 2009; 84(12):1130-46. PMC: 2787400. DOI: 10.4065/mcp.2009.0391. View

Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R . Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol. 2011; 57(24):2389-97. DOI: 10.1016/j.jacc.2011.02.032. View

Tang E, Wong C, Herbison P . Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J. 2006; 153(1):29-35. DOI: 10.1016/j.ahj.2006.10.004. View

Cascio M, DeLoughery T . Anemia: Evaluation and Diagnostic Tests. Med Clin North Am. 2017; 101(2):263-284. DOI: 10.1016/j.mcna.2016.09.003. View

Lin B, Koibuchi N, Hasegawa Y, Sueta D, Toyama K, Uekawa K . Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice. Cardiovasc Diabetol. 2014; 13:148. PMC: 4219031. DOI: 10.1186/s12933-014-0148-1. View

10.

Cannon C, Shah S, Dansky H, Davidson M, Brinton E, Gotto A . Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med. 2010; 363(25):2406-15. DOI: 10.1056/NEJMoa1009744. View

11.

Dong Z, Liang Z, Guo M, Hu S, Shen Z, Hai X . The Association between Plasma Levels of Trimethylamine N-Oxide and the Risk of Coronary Heart Disease in Chinese Patients with or without Type 2 Diabetes Mellitus. Dis Markers. 2018; 2018:1578320. PMC: 6109488. DOI: 10.1155/2018/1578320. View

12.

Eagle K, Lim M, Dabbous O, Pieper K, Goldberg R, Van de Werf F . A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004; 291(22):2727-33. DOI: 10.1001/jama.291.22.2727. View

13.

De Luca G, Verdoia M, Suryapranata H . Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. Atherosclerosis. 2012; 222(2):426-33. DOI: 10.1016/j.atherosclerosis.2012.02.041. View

14.

Ludidi A, Baloyi M, Khathi A, Sibiya N, Ngubane P . The effects of Momordica balsamina methanolic extract on haematological function in streptozotocin-induced diabetic rats: Effects on selected markers. Biomed Pharmacother. 2019; 116:108925. DOI: 10.1016/j.biopha.2019.108925. View

15.

Bagnall A, Spyridopoulos I . The evidence base for revascularisation of chronic total occlusions. Curr Cardiol Rev. 2014; 10(2):88-98. PMC: 4021288. DOI: 10.2174/1573403x10666140331125659. View

16.

Mao Q, Zhou D, Li Y, Wang Y, Xu S, Zhao X . The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. Dis Markers. 2019; 2019:6891537. PMC: 6594265. DOI: 10.1155/2019/6891537. View

17.

Zhan Y, Zou B, Kang T, Xiong L, Zou J, Wei Y . Multiplicative interaction between mean corpuscular volume and red cell distribution width with target organ damage in hypertensive patients. J Clin Lab Anal. 2016; 31(5). PMC: 6817284. DOI: 10.1002/jcla.22082. View

18.

Zhao Z, Xu Y, Li S, Guo J, Sun J, Hong J . Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention. Dis Markers. 2019; 2019:4925767. PMC: 6854229. DOI: 10.1155/2019/4925767. View

19.

De Luca G, Dirksen M, Spaulding C, Kelbaek H, Schalij M, Thuesen L . Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation. Diabetes Care. 2013; 36(4):1020-5. PMC: 3609523. DOI: 10.2337/dc12-1507. View

20.

Jagadish S, Hemshekhar M, NaveenKumar S, Sharath Kumar K, Sundaram M, Basappa . Novel oxolane derivative DMTD mitigates high glucose-induced erythrocyte apoptosis by regulating oxidative stress. Toxicol Appl Pharmacol. 2017; 334:167-179. DOI: 10.1016/j.taap.2017.09.008. View